Literature DB >> 295037

Evaluation of the BIOSTATOR systems glucose analyzer.

E J Fogt, L M Dodd, A R Eddy, E Jenning, A H Clemens.   

Abstract

The BIOSTATOR Systems have an on-line glucose analyzer for use with whole blood. This analyzer utilizes a novel enzyme (glucose oxidase) membrane configuration and an electrochemical cell to measure the H2O2 generated. The analyzer response is fast, accurate, precise, stable, and linearly related to the blood glucose concentration over the full range of clinical interest. Extensive correlation studies have been completed to show the agreement between this analyzer and the U.S. Food and Drug Administration's recommended hexokinase-glucose-6-phosphate dehydrogenase procedure. In addition, studies on potentially interfering substance and the differences in whole blood and plasma glucose levels have been completed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 295037

Source DB:  PubMed          Journal:  Horm Metab Res Suppl        ISSN: 0170-5903


  1 in total

1.  Design of a prospective clinical study on the agreement between the Continuous GlucoseMonitor, a novel device for CONTinuous ASSessment of blood GLUcose levels, and the RAPIDLab® 1265 blood gas analyser: The CONTASSGLU study.

Authors:  Johannes B Zimmermann; Monika Lehmann; Stefan Hofer; Johannes Hüsing; Catharina Alles; Jens Werner; Jürgen Stiller; Wolfgang Künnecke; Steffen Luntz; Johann Motsch; Markus A Weigand
Journal:  BMC Anesthesiol       Date:  2012-09-22       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.